Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

5.62
-0.1500-2.60%
Post-market: 5.50-0.1200-2.14%19:08 EDT
Volume:1.41M
Turnover:7.89M
Market Cap:304.52M
PE:-1.56
High:5.79
Open:5.56
Low:5.46
Close:5.77
Loading ...

Envista Smile Project Donates $1.8 Million in 2024

PR Newswire
·
26 Feb

United Opens Grab-and-Go Club in Houston

PR Newswire
·
25 Feb

DEXIS Showcases Newest Technology at Chicago Midwinter and Lab Day Conferences

ACCESS Newswire
·
19 Feb

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

GlobeNewswire
·
18 Feb

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

GlobeNewswire
·
07 Feb

Envista Reports Fourth Quarter 2024 Results

PR Newswire
·
06 Feb

Envista to hold Capital Markets Day on March 5, 2025

PR Newswire
·
05 Feb

DEXIS Reflects on a Year of Innovation and Unveils Exciting Plans for 2025

ACCESS Newswire
·
03 Feb

Emergent Biosolutions Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Jan

BRIEF-Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

Reuters
·
16 Jan

Emergent BioSolutions Inc - First Interim Analysis of Mosa Trial Expected by End of Q1 2025

THOMSON REUTERS
·
16 Jan

Enrollment Starts in Africa Cdc-Led Mpox Therapeutic Study (Mosa)

THOMSON REUTERS
·
16 Jan

Emergent BioSolutions Shares up 4.3% on Gaining Commercial Rights for Hikma's Opioid Overdose Treatment

THOMSON REUTERS
·
14 Jan

BUZZ-Emergent up on gaining commercial rights for Hikma's opioid overdose treatment

Reuters
·
14 Jan

Emergent BioSolutions Obtains Commercial Rights to Kloxxado Nasal Spray

MT Newswires Live
·
14 Jan

Emergent BioSolutions, Hikma enter partnership for sale of Kloxxado nasal spray

TIPRANKS
·
14 Jan